Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios

The effective management of OFF episodes remains an important unmet need for patients with Parkinson’s disease (PD) who develop motor complications with long-term levodopa therapy. Istradefylline is a selective adenosine A(2A) receptor antagonist for the treatment of patients with PD experiencing OF...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaacson, Stuart H, Betté, Sagari, Pahwa, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329678/
https://www.ncbi.nlm.nih.gov/pubmed/35910426
http://dx.doi.org/10.2147/DNND.S245197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329678/
https://www.ncbi.nlm.nih.gov/pubmed/35910426
http://dx.doi.org/10.2147/DNND.S245197

Ejemplares similares